Tower Research Capital LLC (Trc) Concert Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$4.34 - $5.84 $23,223 - $31,249	5,351 Added 261.41%	7,398 $43,000
Q3 2022 Nov 10, 2022	SELL	$4.27 - $7.2 $115,994 - $195,588	-27,165 Reduced 92.99%	2,047 $14,000
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $11,774 - $26,743	4,205 Added 16.82%	29,212 $123,000
Q1 2022 May 12, 2022	BUY	$2.73 - $3.94 $30,892 - $44,585	11,316 Added 82.65%	25,007 $84,000
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $27,884 - $43,744	10,366 Added 311.76%	13,691 $44,000
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $9,430 - $12,346	-2,975 Reduced 47.22%	3,325 $11,000
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $16,554 - $23,008	-4,391 Reduced 41.07%	6,300 $27,000
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $25,388 - $68,277	5,224 Added 95.56%	10,691 $53,000
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $234,639 - $317,802	-24,751 Reduced 81.91%	5,467 $69,000
Q3 2020 Nov 16, 2020	BUY	$8.67 - $10.82 $217,651 - $271,625	25,104 Added 490.89%	30,218 $297,000
Q2 2020 Aug 13, 2020	BUY	$7.8 - $11.52 $39,889 - $58,913	5,114 New	5,114 $51,000
Q1 2020 May 15, 2020	SELL	$5.98 - $13.09 $2,445 - $5,353	-409 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$5.71 - $9.22 $1,553 - $2,507	-272 Reduced 39.94%	409 $4,000
Q3 2019 Nov 05, 2019	BUY	$5.88 - $12.35 $4,004 - $8,410	681 New	681 $4,000
Q2 2019 Aug 13, 2019	SELL	$9.44 - $13.12 $2,718 - $3,778	-288 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$12.07 - $17.54 $7,664 - $11,137	-635 Reduced 68.8%	288 $3,000
Q4 2018 Feb 14, 2019	BUY	$11.25 - $16.17 $10,383 - $14,924	923 New	923 $12,000
Q3 2018 Nov 13, 2018	SELL	$12.82 - $17.88 $58,164 - $81,121	-4,537 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$16.83 - $21.66 $76,357 - $98,271	4,537 New	4,537 $76,000
Q4 2017 Feb 09, 2018	SELL	$13.96 - $29.05 $48,245 - $100,396	-3,456 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $48,072 - $52,911	3,456	3,456 $51,000

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account